Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | CCR6 | P51684 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | ALPG | P10696 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4635968 | 0.79 | GSK3A (0.50) | GSK3AGSK3BCCR6SMN1; SMN2ALDH1A1 | |
| SCHEMBL11965744 | 0.76 | — | — | |
| SCHEMBL1313262 | 0.76 | — | — | |
| SCHEMBL18011906 | 0.76 | — | — | |
| Water SCHEMBL28081772 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL11735135 | 0.73 | — | — | |
| SCHEMBL7606220 | 0.72 | EPHX1 (0.33) | EPHX1TSHRHSD17B10SMN1; SMN2ALDH1A1 | |
| SCHEMBL7609948 | 0.72 | EPHX1 (0.33) | EPHX1TSHRHSD17B10SMN1; SMN2ALDH1A1 | |
| Propane SCHEMBL28392088 | 0.71 | GSK3A (0.73) | GSK3AGSK3BCCR6CYP2C19ALDH1A1 | |
| Propane SCHEMBL28032534 | 0.71 | GSK3A (0.73) | GSK3AGSK3BCCR6CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1620488-B1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NAT STARCH CHEM INVEST (US) | 2008-06-18 | — | — | EP | disclosed |
| US-7319132-B2 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |
| EP-1736473-A2 | Oxetane compounds containing maleimide functionality | National Starch and Chemical Investment Holding Corporation (US) | 2006-12-27 | — | — | EP | disclosed |
| US-7034064-B2 | Method of attaching a die to a substrate using a hybrid oxetane compound | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-04-25 | — | — | US | disclosed |
| EP-1620430-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1620488-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| US-6982338-B2 | Oxetane compounds containing maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-01-03 | — | — | US | disclosed |
| US-20050209437-A1 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2005-09-22 | — | — | US | disclosed |
| WO-2004101550-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101646-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225074-A1 | Adhesive compositions containing hybrid oxetane compounds | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | OXGR1, DUOX2, JMJD6 | GSK3A 4641/4885GSK3B 4573/4885CCR6 3222/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.